The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Purdue Pharma’s Sackler family owners have struck a new agreement ... hospitals and other plaintiffs alleging the company mismarketed its drugs and fueled addiction. Many lawsuits also targeted the ...

NEW YORK (Reuters) -Purdue Pharma and its Sackler family owners have reached a new ... The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose ...

As the father of an 18-year-old girl who died from a single OxyContin pill in 2006 and as a creditor in the Purdue Pharma bankruptcy proceeding, I must voice my strong disappointment in Illinois ...

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

By Nadia Ramlagan Public News Service As opioid settlement money continues to flow into Kentucky, counties are having to make ...